Fujian Cosunter Pharmaceutical Co., Ltd. — Investor Relations & Filings
Fujian Cosunter Pharmaceutical Co., Ltd. specializes in the research, development, production, and commercialization of pharmaceutical products. The company maintains a strong focus on antiviral therapies, particularly for the treatment of chronic Hepatitis B, with a product portfolio featuring Entecavir, Tenofovir Disoproxil Fumarate, and Adefovir Dipivoxil. Its therapeutic reach extends to cardiovascular, respiratory, and digestive system medications. The organization operates integrated manufacturing platforms and research centers dedicated to the innovation of small molecule drugs and high-end generic formulations. By leveraging advanced chemical synthesis and formulation technologies, the company delivers a diverse range of therapeutic solutions aimed at addressing unmet medical needs and improving patient health outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 国联民生证券承销保荐有限公司关于福建广生堂药业股份有限公司2025年度向特定对象发行A股股票之上市保荐书 | 2026-01-12 | Chinese | |
| 关于福建广生堂药业股份有限公司申请向特定对象发行股票的审核问询函的回复 | 2026-01-12 | Chinese | |
| 关于创新药子公司参与新发突发与重大传染病防控国家科技重大专项的公告 | 2026-01-05 | Chinese | |
| 国浩律师（上海）事务所关于福建广生堂药业股份有限公司2025年第三次临时股东大会法律意见书 | 2025-11-21 | Chinese | |
| 关于2025年第三次临时股东大会决议的公告 | 2025-11-21 | Chinese | |
| 关于选举第五届董事会职工代表董事的公告 | 2025-11-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 37345312 | 国联民生证券承销保荐有限公司关于福建广生堂药业股份有限公司2025年度向特定对象发行A股股票之上市保荐书 | 2026-01-12 | Chinese | ||
| 37345310 | 关于福建广生堂药业股份有限公司申请向特定对象发行股票的审核问询函的回复 | 2026-01-12 | Chinese | ||
| 37345309 | 关于创新药子公司参与新发突发与重大传染病防控国家科技重大专项的公告 | 2026-01-05 | Chinese | ||
|
2025
12 filings
| |||||
| 37345305 | 国浩律师（上海）事务所关于福建广生堂药业股份有限公司2025年第三次临时股东大会法律意见书 | 2025-11-21 | Chinese | ||
| 37345302 | 关于2025年第三次临时股东大会决议的公告 | 2025-11-21 | Chinese | ||
| 37345300 | 关于选举第五届董事会职工代表董事的公告 | 2025-11-21 | Chinese | ||
| 37345296 | 募集资金管理办法（2025年10月） | 2025-10-29 | Chinese | ||
| 37345294 | 关于第五届董事会第十三次会议决议的公告 | 2025-10-29 | Chinese | ||
| 37345292 | 公司章程（2025年10月） | 2025-10-29 | Chinese | ||
| 37345288 | 独立董事制度（2025年10月） | 2025-10-29 | Chinese | ||
| 37345286 | 审计委员会议事规则（2025年10月） | 2025-10-29 | Chinese | ||
| 37345285 | 董事会议事规则（2025年10月） | 2025-10-29 | Chinese | ||
| 37345283 | 股东会议事规则（2025年10月） | 2025-10-29 | Chinese | ||
| 37345274 | 信息披露事务管理制度（2025年10月) | 2025-10-29 | Chinese | ||
| 37345267 | 关联交易规则（2025年10月） | 2025-10-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Fujian Cosunter Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55423/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55423 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55423 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55423 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55423}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fujian Cosunter Pharmaceutical Co., Ltd. (id: 55423)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.